These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 12128158)
21. Relative exchangeable copper: A valuable tool for the diagnosis of Wilson disease. Guillaud O; Brunet AS; Mallet I; Dumortier J; Pelosse M; Heissat S; Rivet C; Lachaux A; Bost M Liver Int; 2018 Feb; 38(2):350-357. PubMed ID: 28719006 [TBL] [Abstract][Full Text] [Related]
22. Effect of nociceptin/orphanin FQ on the rewarding properties of morphine. Ciccocioppo R; Angeletti S; Sanna PP; Weiss F; Massi M Eur J Pharmacol; 2000 Sep; 404(1-2):153-9. PubMed ID: 10980274 [TBL] [Abstract][Full Text] [Related]
23. Wilson disease. Langner C; Denk H Virchows Arch; 2004 Aug; 445(2):111-8. PubMed ID: 15205951 [TBL] [Abstract][Full Text] [Related]
24. [The onset of psychiatric disorders and Wilson's disease]. Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784 [TBL] [Abstract][Full Text] [Related]
25. Three novel mutations in the ATP7B gene of unrelated Vietnamese patients with Wilson disease. Huong NTM; Lien NTK; Ngoc ND; Mai NTP; Hoa NPA; Hai LT; Van Chi P; Van TT; Van Khanh T; Hoang NH BMC Med Genet; 2018 Jun; 19(1):104. PubMed ID: 29914392 [TBL] [Abstract][Full Text] [Related]
27. Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation. Buiakova OI; Xu J; Lutsenko S; Zeitlin S; Das K; Das S; Ross BM; Mekios C; Scheinberg IH; Gilliam TC Hum Mol Genet; 1999 Sep; 8(9):1665-71. PubMed ID: 10441329 [TBL] [Abstract][Full Text] [Related]
28. Clinical zinc deficiency as early presentation of Wilson disease. Van Biervliet S; Küry S; De Bruyne R; Vanakker OM; Schmitt S; Vande Velde S; Blouin E; Bézieau S J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):457-9. PubMed ID: 25825851 [TBL] [Abstract][Full Text] [Related]
29. Distribution of nociceptin/orphanin FQ in adult human brain. Witta J; Palkovits M; Rosenberger J; Cox BM Brain Res; 2004 Jan; 997(1):24-9. PubMed ID: 14715146 [TBL] [Abstract][Full Text] [Related]
30. Wilson disease. Huster D Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):531-9. PubMed ID: 20955957 [TBL] [Abstract][Full Text] [Related]
31. Activation of Autophagy, Observed in Liver Tissues From Patients With Wilson Disease and From ATP7B-Deficient Animals, Protects Hepatocytes From Copper-Induced Apoptosis. Polishchuk EV; Merolla A; Lichtmannegger J; Romano A; Indrieri A; Ilyechova EY; Concilli M; De Cegli R; Crispino R; Mariniello M; Petruzzelli R; Ranucci G; Iorio R; Pietrocola F; Einer C; Borchard S; Zibert A; Schmidt HH; Di Schiavi E; Puchkova LV; Franco B; Kroemer G; Zischka H; Polishchuk RS Gastroenterology; 2019 Mar; 156(4):1173-1189.e5. PubMed ID: 30452922 [TBL] [Abstract][Full Text] [Related]
32. Spectrum of ATP7B mutations and genotype-phenotype correlation in large-scale Chinese patients with Wilson Disease. Cheng N; Wang H; Wu W; Yang R; Liu L; Han Y; Guo L; Hu J; Xu L; Zhao J; Han Y; Liu Q; Li K; Wang X; Chen W Clin Genet; 2017 Jul; 92(1):69-79. PubMed ID: 27982432 [TBL] [Abstract][Full Text] [Related]
34. [Unusual history of Wilson disease: a case report and review of the literature]. Nehaj F; Kubašková M; Mokáň M; Sokol J; Nosáľ V; Zeleňák K; Mokáň M Vnitr Lek; 2018; 63(12):980-986. PubMed ID: 29334749 [TBL] [Abstract][Full Text] [Related]
35. Molecular mechanism of copper transport in Wilson disease. Fatemi N; Sarkar B Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):695-8. PubMed ID: 12426114 [TBL] [Abstract][Full Text] [Related]
36. Disturbed copper transport in humans. Part 2: mutations of the ATP7B gene lead to Wilson disease (WD). Seidel J; Caca K; Schwab SG; Berr F; Wildenauer DB; Mentzel HJ; Horn N; Kauf E Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL149-57. PubMed ID: 11936861 [TBL] [Abstract][Full Text] [Related]
37. Plasma nociceptin/orphanin FQ levels are lower in patients with chronic ischemic cardiovascular diseases--A pilot study. Krepuska M; Sótonyi P; Csobay-Novák C; Szeberin Z; Hartyánszky I; Zima E; Szilágyi N; Horkay F; Merkely B; Acsády G; Tekes K Regul Pept; 2011 Aug; 169(1-3):1-5. PubMed ID: 21310194 [TBL] [Abstract][Full Text] [Related]
38. Tonic inhibition by orphanin FQ/nociceptin of noradrenaline neurotransmission in the amygdala. Kawahara Y; Hesselink MB; van Scharrenburg G; Westerink BH Eur J Pharmacol; 2004 Feb; 485(1-3):197-200. PubMed ID: 14757141 [TBL] [Abstract][Full Text] [Related]
39. [Plasma levels of nociceptin/orphanin FQ in patients with bipolar disorders and health adults]. Wang LN; Liu LF; Zhang JX; Zhao GF Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):916-8. PubMed ID: 19671295 [TBL] [Abstract][Full Text] [Related]
40. Daily intravesical instillation of 1 mg nociceptin/orphanin FQ for the control of neurogenic detrusor overactivity: a multicenter, placebo controlled, randomized exploratory study. Lazzeri M; Calò G; Spinelli M; Malaguti S; Guerrini R; Salvadori S; Beneforti P; Regoli D; Turini D J Urol; 2006 Nov; 176(5):2098-102. PubMed ID: 17070267 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]